FindMyKOL
Clinical trialNCT01677390TerminatedPhase 1Interventional

A Phase 1b Study of SGN-75 in Combination With Everolimus in Patients With Renal Cell Carcinoma

SponsorSeagen Inc.Enrollment4Renal Cell Carcinoma
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a phase 1, open-label, dose-escalation clinical trial to evaluate the safety of SGN-75 in combination with everolimus in patients with CD70-positive metastatic renal cell carcinoma.

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

8 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Stanford Cancer Center

    Stanford, California, United States

  • Rocky Mountain Cancer Centers - Midtown

    Denver, Colorado, United States

  • Karmanos Cancer Institute / Wayne State University

    Detroit, Michigan, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, United States

  • Unc Lineberger Comprehensive Cancer Center / University of North Carolina

    Chapel Hill, North Carolina, United States

  • Miriam Hospital, the

    Providence, Rhode Island, United States

  • Sarah Cannon Research Institute

    Nashville, Tennessee, United States

  • Seattle Cancer Care Alliance / University of Washington

    Seattle, Washington, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 Aug 2012
Primary completion
31 Dec 2013
Completion
31 Dec 2013
Last update posted
28 Jan 2014
Registered enrollment
4
Registry id
NCT01677390

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 18 Nov 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.